In addition to our discovery programme, Syntopix Services Ltd offers consultancy and contract research to the pharmaceutical and healthcare sector. Services include:
Repositioning screening services
Syntopix has proven methodologies for identifying, screening and
repositioning known compounds for their suitability as topical
antimicrobial drugs or healthcare compounds. We have the
capacity to conduct screening against any microorganism;
Consultancy
Syntopix can provide world-class consultancy on all aspects of
skin microbiology and antibiotic resistance in bacteria;
In vitro evaluation
Our in-house expertise can be accessed to carry out in vitro evaluation of novel treatments for skin infections and acne; and
Propionibacterium Culture Collection
Syntopix can screen anti-infective compounds or products against
a large, diverse and well-characterised global panel of
Propionibacterium isolates.
For further information please contact Dr Jon Cove.
Email: jon@syntopix.com
Tel. +44 (0)845 125 9204
23/08/2010 07:00
AGREEMENT WITH GLOBAL CONSUMER PRODUCTS COMPANY
Syntopix signs an exclusive agreement with a world leading health and personal care brands company.
22/06/2010 07:00
Syntopix welcomes a new board member with Mike Townend joining as Non-executive Director
22/04/2009 13:13
03/02/2010 07:00
Syntopix announces a Directorate change with Tom Bannatyne joining as Chairman.
12/11/2009 07:00
Syntopix announces positive results for its lead dermatological compound SYN0126